Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. It’s what helped ...

Health Care Health Care   The Big Story MAHA leaders heading for clash over GLP-1 drugs Two of President-elect Trump’s top ...

Taking a glp-1 medication for weight loss isn't appropriate for everyone. There are side effects and costs to consider.

Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he knew ...

Roche Holding CEO Thomas Schinecker reassures no job cuts planned, discusses future drug launches and economic challenges in Europe, US, and China.

Novo's lead drug is semaglutide, a glucagon-line peptide-1 (GLP-1) agonist that the Food and Drug Administration (FDA) approved as Ozempic and Rybelsus to treat diabetes and later as Wegovy to treat ...

There are many medical conditions linked to obesity ranging from cardiovascular diseases to cancers. Modern lifestyles have ...

Lottery ticket check online Henan Province will launch a three-month campaign to rectify hidden risks of drugs and medical devices New study ...

Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.

Losing weight on a GLP-1 can lead to muscle loss, research shows. Here, obseity experts share how to preserve your lean ...